Study of Ciforadenant in Combination With Daratumumab in Patients With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT04280328 · COMPLETED
Trial details
- NCT number
- NCT04280328
- Sponsor
- Corvus Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-20
- Primary completion
- 2021-09-21
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.